POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a hormone mimic curb the need for bloodletting in a blood cancer?
Disease control Not yet recruitingThis trial tests whether rusfertide, a synthetic version of the hormone hepcidin, can help people with polycythemia vera—a condition where the bone marrow makes too many red blood cells—by lowering iron availability and keeping red blood cell counts in check. The study enrolls Ch…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new drug help when standard treatment fails for polycythemia vera?
Disease control Not yet recruitingThis trial tests whether an experimental drug called bomedemstat can help people with polycythemia vera (a condition where the body makes too many red blood cells) who did not get better with or could not tolerate the common treatment hydroxyurea. Participants will receive either…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New oral drug could tame overactive bone marrow in rare blood cancers
Disease control Not yet recruitingThis study tests a pill called selinexor in 15 adults with chronic blood cancers (MPN) whose blood cell counts are too high. The goal is to see if selinexor can safely bring those counts down and ease symptoms. Participants take the drug once a week for up to 3 months and are fol…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Personalized exercise shows promise for fatigue in rare blood cancers
Symptom relief Not yet recruitingThis study tests whether a 12-week personalized exercise program can reduce fatigue and improve physical function in people with myeloproliferative neoplasms (MPN) and chronic myeloid leukemia (CML). Participants will do supervised aerobic and resistance training twice a week plu…
Matched conditions: POLYCYTHEMIA VERA
Phase: NA • Sponsor: Carmen Fava • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
A simple Note-Taking change could transform blood cancer care
Knowledge-focused Not yet recruitingThis quality improvement initiative tests whether a standardized electronic medical record template for progress notes, combined with a pharmacist-led medication titration service, can improve the management of polycythemia vera (PV). The study enrolls hematologists and oncologis…
Matched conditions: POLYCYTHEMIA VERA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC